Literature DB >> 16342217

Aortic counterpulsation: a review of the hemodynamic effects and indications for use.

Richard A Santa-Cruz1, Mauricio G Cohen, E Magnus Ohman.   

Abstract

In the ever evolving field of cardiovascular medicine and coronary intervention, the intra-aortic balloon pump (IABP) is a mature technology, which still plays an important role. The balloon pump invasively supports patient hemodynamics by augmenting diastolic perfusion and increasing diastolic blood pressure, thereby increasing coronary perfusion and reducing afterload. Its efficacy has been demonstrated in a multitude of clinical situations, including acute coronary syndromes, high-risk coronary interventions, cardiogenic shock, and cardiovascular surgery. The potential complications of aortic counterpulsation are serious, although much lower than once feared. With proper patient selection, insertion technique, and management, the IABP is a powerful tool to assist in the treatment of patients with cardiovascular disease. This article will review the hemodynamics, indications, and complications associated with its use.

Entities:  

Mesh:

Year:  2006        PMID: 16342217     DOI: 10.1002/ccd.20552

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  17 in total

1.  Aortic Counterpulsation Therapy in Patients with Advanced Heart Failure: Analysis of the TBRIDGE Registry.

Authors:  Cristiano Guedes Bezerra; Eduardo Leal Adam; Mariana Lins Baptista; Giuliano Serafino Ciambelli; Liliane Kopel; Claudia Bernoche; Leonardo Nicolau Geisler Daud Lopes; Milena Frota Macatrão-Costa; Breno de Alencar Araripe Falcão; Silvia Gelas Lage
Journal:  Arq Bras Cardiol       Date:  2015-12-22       Impact factor: 2.000

Review 2.  Radiology of cardiac devices and their complications.

Authors:  J Dipoce; A Bernheim; H Spindola-Franco
Journal:  Br J Radiol       Date:  2014-11-20       Impact factor: 3.039

3.  IABP plus ECMO-Is one and one more than two?

Authors:  Sebastian Nuding; Karl Werdan
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

4.  First-Line Support by Intra-Aortic Balloon Pump in Non-Ischaemic Cardiogenic Shock in the Era of Modern Ventricular Assist Devices.

Authors:  Corstiaan A den Uil; Giorgia Galli; Lucia S Jewbali; Kadir Caliskan; Olivier C Manintveld; Jasper J Brugts; Nicolas M van Mieghem; Mattie J Lenzen; Eric Boersma; Alina A Constantinescu
Journal:  Cardiology       Date:  2017-05-13       Impact factor: 1.869

5.  Acute Beneficial Effects of Muscular Counterpulsation in Patients with Coronary Heart Diseases.

Authors:  Larry V Lapanashvili; Michael D Alshibaya; Julia Veselova; Leo A Bockeria
Journal:  Int J Angiol       Date:  2016-11-28

6.  Efficacy of Subcutaneous Electrocardiogram Leads for Synchronous Timing During Chronic Counterpulsation Therapy.

Authors:  Stephen R Carnahan; Steven C Koenig; Michael A Sobieski; Erin M Schumer; Gretel Monreal; Yu Wang; Young Choi; Brek J Meuris; Landon H Tompkins; Zhongjun J Wu; Mark S Slaughter; Guruprasad A Giridharan
Journal:  ASAIO J       Date:  2017 Mar/Apr       Impact factor: 2.872

7.  [Prophylactic intraaortic balloon pumping in high-risk cardiac surgery patients].

Authors:  D Metz; M Stiller; R-E Silber; H Kroll; H-S Hofmann; C Diez
Journal:  Med Klin Intensivmed Notfmed       Date:  2011-10-29       Impact factor: 0.840

Review 8.  Percutaneous mechanical devices in the management of decompensated heart failure.

Authors:  Paul J Mather; Marvin A Konstam
Journal:  Curr Heart Fail Rep       Date:  2007-03

9.  Predictors of intra-aortic balloon pump hemodynamic failure in non-acute myocardial infarction cardiogenic shock.

Authors:  Steven Hsu; Swetha Kambhampati; Christopher M Sciortino; Stuart D Russell; Steven P Schulman
Journal:  Am Heart J       Date:  2017-12-13       Impact factor: 4.749

10.  Acute microflow changes after stop and restart of intra-aortic balloon pump in cardiogenic shock.

Authors:  Christian Jung; Christoph Rödiger; Michael Fritzenwanger; Julia Schumm; Alexander Lauten; Hans R Figulla; Markus Ferrari
Journal:  Clin Res Cardiol       Date:  2009-04-15       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.